Cargando…
Rosuvastatin as forthcoming antibiotic or as adjuvant additive agent: In vitro novel antibacterial study
INTRODUCTION: Rosuvastatin is a lipid-lowering agent that inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase leading to a reduction of cholesterol biosynthesis. Many studies have shown an association between statins use and the reduction of sepsis. The aim of the present study was to evaluate...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052819/ https://www.ncbi.nlm.nih.gov/pubmed/30078961 http://dx.doi.org/10.4103/JLP.JLP_170_17 |